Education
About Us
Working with TipRanks
Follow Us
JSMD - ETF AI Analysis
Top Page
Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD)
Rating:70Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several of the ETF's largest positions, such as BWX Technologies and Medpace Holdings, have delivered strong year-to-date performance, supporting overall returns.
Sector Diversification
The ETF is spread across multiple sectors, including Technology, Industrials, and Financials, reducing reliance on any single industry.
Reasonable Expense Ratio
With a competitive expense ratio of 0.3%, the ETF offers relatively low costs compared to actively managed funds.
Negative Factors
High Geographic Concentration
The ETF is almost entirely focused on U.S. companies, limiting exposure to international markets and diversification.
Underperforming Holdings
Some top holdings, such as AppFolio, have shown weak performance year-to-date, which could drag on overall returns.
Sector Overweight Risk
The ETF has significant exposure to Technology and Industrials, which could increase vulnerability if these sectors face downturns.
JSMD vs. SPDR S&P 500 ETF (SPY)
AUM725.23M
RegionNorth America
Expense Ratio0.30%
Beta1.04
IssuerJanus Henderson
Inception DateFeb 23, 2016
Dividend Yield0.87%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume66,052
30 Day Avg. Volume51,719
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
94.86Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering106
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
JSMD Summary
The Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) is an investment fund focused on small and mid-sized companies in the U.S. that have strong growth potential. It includes businesses from various industries like technology, healthcare, and consumer goods. Some of its top holdings are Medpace Holdings and BWX Technologies, which are leaders in their fields. This ETF is a good option for investors looking to diversify their portfolio and benefit from the agility and innovation of smaller companies. However, new investors should be aware that small and mid-cap stocks can be more volatile, meaning their value can rise or fall quickly.
How much will it cost me?The Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) has an expense ratio of 0.3%, which means you’ll pay $3 per year for every $1,000 invested. This is slightly higher than the average for ETFs because it is actively managed, focusing on selecting small and mid-sized companies with growth potential. Active management typically involves more research and decision-making, which can increase costs.
What would affect this ETF?JSMD's focus on small and mid-cap growth companies in sectors like technology, industrials, and healthcare positions it to benefit from innovation and economic expansion in the U.S. However, it could face challenges from rising interest rates, which may impact growth stocks, and economic slowdowns that disproportionately affect smaller companies. Regulatory changes or sector-specific disruptions could also influence its performance.
JSMD Top 10 Holdings
The Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) leans heavily into technology and industrials, with these sectors driving nearly half of its portfolio. Medpace Holdings and Sanmina-Sci are rising stars, delivering robust growth and momentum that energize the fund’s performance. On the flip side, BWX Technologies and Installed Building Products are lagging, weighed down by bearish technical signals and leverage concerns. With its focus on U.S.-based small and mid-cap companies, JSMD offers a dynamic mix of innovation and agility, though its sector concentration means investors should keep an eye on potential volatility.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Medpace Holdings | 3.07% | $22.54M | $16.44B | 73.31% | 79 Outperform | |
| Sanmina-Sci | 2.78% | $20.46M | $8.41B | 92.74% | 78 Outperform | |
| BWX Technologies | 2.33% | $17.11M | $16.11B | 35.39% | 69 Neutral | |
| Installed Building Products | 2.31% | $17.00M | $7.14B | 17.88% | 68 Neutral | |
| Halozyme | 2.30% | $16.92M | $7.82B | 37.25% | 74 Outperform | |
| Argan | 2.21% | $16.28M | $4.94B | 138.46% | 75 Outperform | |
| TopBuild | 2.17% | $15.94M | $12.55B | 13.85% | 77 Outperform | |
| Jabil | 2.14% | $15.77M | $22.65B | 54.97% | 61 Neutral | |
| Clear Secure | 2.08% | $15.29M | $4.65B | 34.81% | 79 Outperform | |
| Primoris Services | 2.00% | $14.70M | $6.74B | 47.70% | 71 Outperform |
JSMD Technical Analysis
Positive
―
Price Trends
82.90
Negative
82.01
Positive
77.12
Positive
Market Momentum
-0.33
Negative
49.68
Neutral
82.29
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JSMD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 81.89, equal to the 50-day MA of 82.90, and equal to the 200-day MA of 77.12, indicating a neutral trend. The MACD of -0.33 indicates Negative momentum. The RSI at 49.68 is Neutral, neither overbought nor oversold. The STOCH value of 82.29 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JSMD.
JSMD Peer Comparison
Comparison Results
Performance Comparison
JSMD
Janus Henderson Small/Mid Cap Growth Alpha ETF
82.08
0.05
0.06%
RSMC
Rockefeller U.S. Small-Mid Cap ETF
―
―
―
MSSM
Morgan Stanley Pathway Small-Mid Cap Equity ETF
―
―
―
CSMD
Congress SMid Growth ETF
―
―
―
NBSM
Neuberger Berman Small-Mid Cap ETF
―
―
―
SMIZ
Zacks Small/Mid Cap ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents